Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8c76de8b653a892db5a3bd639dd35af http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d68883e5a13d8ebd0b265736edd4e25a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2240-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29K2105-0035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29K2995-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29K2067-046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C53-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29L2031-7534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C67-0014 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C69-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C67-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C53-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C67-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29C69-002 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-89 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29C69-00 |
filingDate |
2018-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a1ae212e0ea5bd5f97db4f0cb7c7fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bec58dd5b5214208c624b42790aa0aa |
publicationDate |
2019-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019209354-A1 |
titleOfInvention |
Bioresorbable scaffold having sustained drug delivery |
abstract |
A multilayer bioresorbable stent having sustained drug delivery is disclosed herein. The bioresorbable stent releases a therapeutic substance from the body of the bioresorbable stent starting when the bioresorbable stent is implanted within an anatomical lumen and ending when the entire mass of the bioresorbable stent is no longer present within the anatomical lumen. The bioresorbable stent releases the therapeutic substance gradually during the treatment as the mass of the each layer of the bioresorbable stent erodes. Methods of making the therapeutic layers within the bioresorbable sent are further disclosed. Sustained drug delivery reduces the risk of late and very late stent thrombosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497595-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114225121-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2773195-C2 |
priorityDate |
2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |